QuidelOrtho Corporation
QDEL
$0.96 (-6.81%)
1D
1W
3M
1Y
5Y
ALL
QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 11 hours ago • QDEL
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
Zacks Investment Research • 6 days ago • QDEL
Is the Options Market Predicting a Spike in QuidelOrtho Stock?
Zacks Investment Research • 13 days ago • QDEL
QuidelOrtho (QDEL) Up 24.1% Since Last Earnings Report: Can It Continue?
Zacks Investment Research • 14 days ago • QDEL
QuidelOrtho's Respiratory Exposure Remains a Key Near-Term Risk
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.